Wendy Britten

Congenica has named Wendy Britton chief financial officer, effective Sept. 1. Britten joins the British clinical genomics interpretation software vendor from AstraZeneca, where she led group finance business performance. In addition to the normal CFO responsibilities, Britten will have a say in Congenica's business development and future fundraising, the company said. In announcing Britten's hiring, Congenica disclosed that it raised $13.5 million in a Series B that concluded in April 2017, higher than the $10 million reported two months earlier.